Elekta AB (publ) announced that its Elekta Harmony radiation therapy system recently received U.S. FDA 510(k) clearance, paving the way for U.S. clinics to harness the system to treat a comprehensive range of indications using the latest radiotherapy techniques. Harmony perfectly balances productivity and precision without compromise, making the system well-suited to address changing U.S. demographics and practice patterns. Harmony will provide enhanced: Productivity: the new FastTrack in-room experience reduces patient setup time by as much as 50%.** Combined with further workflow enhancements, treatment slots can be reduced by up to 25%**, enabling clinicians to deliver high-quality cancer care to more patients. Precision: a best-in-class multi-leaf collimator provides one-millimeter resolution beam-shaping across the full 40 cm X 40 cm field size, which provides "shrink-wrapped" sub-millimeter conformality around the tumor target. Versatility: the option of multiple energies, treatment techniques and imaging modalities, providing the versatility needed to treat the most common indications, including breast, lung, pelvic and head-and-neck cancers.